A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes.
May 15, 2012
112th Congress, 2011–2013
Enacted — Signed by the President on Jul 9, 2012
This bill was enacted after being signed by the President on July 9, 2012.
Senator from Iowa
Read Text »
Last Updated: Jun 27, 2012
Length: 140 pages
S. 3187 (112th) was a bill in the United States Congress.
A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
This bill was introduced in the 112th Congress, which met from Jan 5, 2011 to Jan 3, 2013. Legislation not enacted by the end of a Congress is cleared from the books.
How to cite this information.
We recommend the following MLA-formatted citation when using the information you see here in academic work:
Civic Impulse. (2016). S. 3187 — 112th Congress: Food and Drug Administration Safety and Innovation Act. Retrieved from https://www.govtrack.us/congress/bills/112/s3187
“S. 3187 — 112th Congress: Food and Drug Administration Safety and Innovation Act.” www.GovTrack.us. 2012. December 10, 2016 <https://www.govtrack.us/congress/bills/112/s3187>
|title=S. 3187 (112th)
|accessdate=December 10, 2016
|author=112th Congress (2012)
|date=May 15, 2012
|quote=Food and Drug Administration Safety and Innovation Act
Where is this information from?
GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.